Migraine trials in Belgium

4 of 4 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

  Where

  Brugge, Edegem

  Age

  6 years to 17 years

  People

  450 worldwide

  Run by

  AbbVie

  See details and how to joinNCT05711394 · EU 2022-501100-94-00
• No phaseTaking people
  The RECLAIM Study.

  Where

  Bruges, Hasselt, Kortrijk, Ostend, Roeselare, Saint-Nicolas, Wilrijk

  Age

  18 years to 84 years

  People

  110 worldwide

  Run by

  Salvia BioElectronics

  See details and how to joinNCT06450444
• Phase 3Taking people
  Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

  Where

  Brugge, Edegem

  Age

  6 years to 17 years

  People

  650 worldwide

  Run by

  AbbVie

  See details and how to joinNCT05707949 · EU 2022-501099-24-00
• No phaseTaking people
  Assessment of the Effectiveness of Virtual Reality as a Learning Tool for Relaxation Techniques in Reducing Pediatric Migraines and Tension Type Headache

  Where

  Sart Tilman

  Age

  8 years to 15 years

  People

  60

  Run by

  University of Liege

  See details and how to joinNCT06921109